These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11125370

  • 1. Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer.
    Vergouwe Y, Steyerberg EW, Foster RS, Habbema JD, Donohue JP.
    J Urol; 2001 Jan; 165(1):84-8; discussion 88. PubMed ID: 11125370
    [Abstract] [Full Text] [Related]

  • 2. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD.
    Cancer; 1997 Jan 15; 79(2):345-55. PubMed ID: 9010108
    [Abstract] [Full Text] [Related]

  • 3. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
    Carver BS, Bianco FJ, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Urol; 2006 Jul 15; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
    [Abstract] [Full Text] [Related]

  • 4. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW, Gerl A, Fossá SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ.
    J Clin Oncol; 1998 Jan 15; 16(1):269-74. PubMed ID: 9440752
    [Abstract] [Full Text] [Related]

  • 5. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
    Albers P, Weissbach L, Krege S, Kliesch S, Hartmann M, Heidenreich A, Walz P, Kuczyk M, Fimmers R, German Testicular Cancer Study Group.
    J Urol; 2004 May 15; 171(5):1835-8. PubMed ID: 15076288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.
    Steyerberg EW, Marshall PB, Keizer HJ, Habbema JD.
    Cancer; 1999 Mar 15; 85(6):1331-41. PubMed ID: 10189139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R.
    J Urol; 2004 Jan 15; 171(1):172-6. PubMed ID: 14665870
    [Abstract] [Full Text] [Related]

  • 12. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L, German Testicular Cancer Study Group.
    J Urol; 2003 May 15; 169(5):1710-4. PubMed ID: 12686815
    [Abstract] [Full Text] [Related]

  • 13. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H, Ghozzi S, Ramzi K, Smaali CH, Majed H, Ben Rais N.
    Tunis Med; 2005 Dec 15; 83 Suppl 12():78-83. PubMed ID: 16430075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B, Grunenwald D, Fléchon A, Caty A, Chevreau C, Culine S, Théodore C, Fizazi K.
    J Thorac Cardiovasc Surg; 2009 Feb 15; 137(2):448-52. PubMed ID: 19185168
    [Abstract] [Full Text] [Related]

  • 17. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan 15; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
    Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL.
    Cancer; 2009 Mar 15; 115(6):1310-7. PubMed ID: 19156903
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.